Detection of alterations in the levels of neuropeptides and salivary gland responses in the non-obese diabetic mouse model for autoimmune sialoadenitis

Scandinavian Journal of Immunology

Volumn 45, Issue 1, 1997, Pages 55-61

  Yamamoto, H ^a,b   Ishibashi, K ^a   Nakagawa, Y ^a   Maeda, N ^a   Zeng, T ^b   Robinson, C P ^b   Oxford, G E ^b   Chegini, N ^b   Humphreys Beher, M G ^b  

^a TSURUMI UNIVERSITY   (Japan)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROPEPTIDE; NEUROPEPTIDE Y; PILOCARPINE; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; ETIOLOGY; FEMALE; IMMUNOHISTOCHEMISTRY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SALIVARY GLAND; SIALOADENITIS;

EID: 0031021385     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1997.d01-375.x     Document Type: Article

References (26)

1. Inanaga A, Habu T, Tanaka E et al. Age changes in secretory function of male and female rat parotid glands in response to methoxamine and pilocarpine. J Dent Res 1988;67:565-73.
2. Asamoto H, Oishi M, Azakawa Y, Tochino Y. Histologic and immunologic changes in the thymus and other organs in NOD mice. In: Seiichiro, T, Tochino, Y, Noraka, K, eds Insulitis and Type 1 Diabetes. Tokyo: Academic, 1986:62-71.
3. Hu Y, Nakagawa Y, Purushotham KR, Humphreys-Beher MG. Functional changes in salivary glands of autoimmune disease-prone NOD mice. Am J Physiol 1992;263:E607-E61.
4. Humphreys-Beher MG, Brinkley L, Purushotham KR et al. Characterization of antinuclear antibodies present in the serum from non obese diabetic (NOD) mice. Clin Immunol Immunopathol 1993;68: 350-6.
5. Hu Y, Purushotham KR, Wang P, Dawson R, Humphreys-Beher MG. Downregulation of β-adrenergic receptors and signal transduction response in salivary glands of NOD mice. Am J Physiol 1994; 266:G433-G443.
6. Yamamoto H, Sims NE, Macauley SP, Nguyen K-HT, Nakagawa Y, Humphreys-Beher MG. Alterations in the secretory response of non-obese diabetic (NOD) mice to muscarinic receptor stimulation. J Clin Immuno Immunopathol 1996; 78:245-55.
7. Humphreys-Beher MG, Hu Y, Nakagawa Y, Wang P-L, Purushotham KR. Utilization of the non-obese diabetic (NOD) mouse as an animal model for the study of secondary Sjögren's syndrome. Adv Exp Med Biol 1994;350:631-6.
8. Garrett JR. Innervation of salivary glands: neurohistological and functional aspects. In: Screebny LM, ed. The Salivary System. Boca Raton: CRC Press, 1988:69-93.
9. Baum BJ, Ito H, Roth GS. Adrenoceptors and the regulation of salivary gland physiology. In: Kunos G, ed. Adrenoreceptors and Catecholamine Action. Part B. New York: John Wiley and Sons, 1983:265-94.
10. Williams JA. Regulatory mechanisms in pancreas and salivary acini. Ann Rev Physiol 1984;46:361-75.
11. Pernow B. Substance P: Its distribution, pharmacological actions and possible physiological role in sensory neurons. Clin Physiol 1981;1: 235-51.
12. Martinez JR, Martinez AM. Stimulatory and inhibitory effects of substance P on rat submandibular secretion. J Dent Res 1981;60: 1031-8.
13. Ekström J, Brodin E, Ekman R, Hkanson R, Sundler F. Vasoactive intestinal peptide and substance P in salivary glands of the rat following denervation or duct ligation. Regulatory Peptides 1984;10:1-10.
14. Inoue Y, Kanno T. Secretory effects of vasoactive intestinal polypeptide (VIP), adrenaline and carbachol in isolated lobules of the rat parotid gland. Biomed Res 1982;3:384-9.
15. Scott J, Baum BJ. Involvement of cyclic AMP and calcium in exocrine protein secretion induced by vasoactive intestinal polypeptide in rat parotid cells. Biochem Biophys Acta 1985;847:255-62.
16. Lundberg JM., Terenius L, Hökfelt T et al. Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function. Acta Physiol Scand 1982;116: 477-80.
17. Lundberg JM, Saria A, Franco-Cereceda A et al. Differential effects of resperine and 6-hydroxydopamine on neuropeptide Y (NPY) and noradrenaline in peripheral neurons. Naunyn-Schmiedebert's Arch Pharmacol 1985;329:331-40.
18. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;7:248-54.
19. Bernfeld P. Amylase, alpha and beta. Meth Enzym 1955;1:149-58.
20. Humphreys-Beher MG, Macauley SP, Chegini N et al. Characterization of the synthesis and secretion of transforming growth factor-α from salivary glands and saliva. Endocrinology 1994;134:963-70.
21. Yeh Y-C, Tsai J-F, Yeh HW, Tsai H-H, Florine D, Tam JP. Elevation of transforming growth factor a and its relationship to the epidermal growth factor and k-fetoprotein levels in patients with hepatocellular carcinoma. Cancer Res 1987;47:896-901.
22. Ekstrom J, Ekman R, Luts A, Sundler F, Tobin G. Neuropeptide Y in salivay glands of the rat: Origin, release and secretory effects. Regulatoy Peptides 1996;61:125-34.
23. 1-adrenergic receptors in patients with malignant hypertension. Lancet 1994;344:1660-3.
24. Fu MLX, Hoeboke J, Matsui S et al. Autoantibodies against cardiac G-protein-coupled receptors define different populations with cardiomyopaathies but not with hypertension. Clin Immunol Immunopathol 1994;72:15-20.
25. Hausdorff WP, Caron MG, Letkowitz RJ. Turning off the signal: densensitzation of β-adrenergic function. FASEB J. 1990;4:2881-9.
26. Hy Y, Humphreys-Beher MG. Decreased levels of adenylate cyclase contribute to the down-reglulation of beta-adrenergic signal transduction in the salivary glands of the non-obese diabetic (NOD) mouse. Autoimmunity 1995;21:137-42.